News

Phathom Pharmaceuticals Details Third Quarter 2024 Performance

Phathom Pharmaceuticals Details Third Quarter 2024 Performance

Phathom Pharmaceuticals Plans Financial Results Presentation

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT), a pioneering biopharmaceutical company at the forefront of innovative treatments for gastrointestinal diseases, is gearing up to unveil its financial performance for the third quarter of 2024. A highly anticipated live webcast will take place to discuss these results and share insights into ongoing business developments.

The Live Webcast Event

The webcast is scheduled for Thursday, November 7, 2024, at 8:30 am ET. This event will serve as an opportunity for investors and analysts to gain valuable updates and understand the latest strategic initiatives taken by Phathom Pharmaceuticals.

Accessing the Webcast

Interested participants can access the live webcast through the Events & Presentations section on the Phathom Pharmaceuticals website. After the event concludes, a recording will be made available for viewing for up to 90 days, ensuring that stakeholders can catch up on any important information they may have missed.

About Phathom Pharmaceuticals

Phathom Pharmaceuticals stands out with its commitment to developing cutting-edge treatments that address chronic gastrointestinal conditions. The company has made strides with its product, vonoprazan, which is distinguished as a first-in-class potassium-competitive acid blocker (PCAB). This innovative drug is already making waves in the marketplace, particularly with its use in treating conditions like heartburn and Erosive GERD.

Innovative Solutions for Gastrointestinal Disorders

Vonoprazan, marketed under the brand name VOQUEZNA, is specifically designed to provide relief from heartburn linked to Non-Erosive GERD, as well as to facilitate the healing of Erosive GERD in adults. Additionally, the product line includes VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK, which combine vonoprazan with antibiotics for effective treatment of H. pylori infections in adults.

Commitment to Patients and Advancement

The ongoing development of these therapies underscores Phathom's commitment to improving patient outcomes and advancing treatment options available in the market. By focusing on innovative approaches, Phathom Pharmaceuticals is poised to play a significant role in the biopharmaceutical landscape, particularly concerning gastrointestinal health.

Media and Investor Relations Contact

For media inquiries or further information, Nick Benedetto can be reached at 1-877-742-8466. Investors looking for more details about the company's performance are encouraged to contact Eric Sciorilli at the same number. Phathom is dedicated to maintaining open lines of communication with stakeholders and the public.

Frequently Asked Questions

What is Phathom Pharmaceuticals known for?

Phathom Pharmaceuticals is recognized for developing innovative treatments for gastrointestinal diseases, particularly through its flagship product, vonoprazan.

When will the financial results be presented?

The financial results for Q3 2024 will be presented on November 7, 2024, at 8:30 am ET during a live webcast.

How can I access the webcast of the financial results?

The webcast will be available on Phathom Pharmaceuticals' website in the Events & Presentations section and will be accessible for 90 days after the event.

What products does Phathom Pharmaceuticals offer?

Phathom Pharmaceuticals offers a range of products, including VOQUEZNA, VOQUEZNA DUAL PAK, and VOQUEZNA TRIPLE PAK, targeting various gastrointestinal conditions.

How does Phathom engage with investors?

Phathom maintains open communication with investors through ongoing updates and dedicated contact points for inquiries and information requests.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Hybrid Bonding Market Shooting to $2.45 Billion by 2033

Updated Category News Views 126

Hybrid Bonding: The Future of Semiconductor Interconnects? Mark these words: Hybrid bonding isn't just another tech trend—it’s morphing into a billion-dollar juggernaut, my friend. With the latest numbers from MarketsandMarkets™, we see a potential leap from USD 0.38 billion in 2026 to a staggering USD 2.45 billion by 2033. We'll be seeing an eye-popping CAGR of...

Continue Reading
vVARDIS Readies for Big Day on NYSE—IPO Set to Shine

Updated Category News Views 166

vVARDIS Stepping into the Spotlight of the NYSE Alright, folks, here's one that could make some waves. vVARDIS is gearing up for its NYSE debut, trading under the ticker VVVV. They're no small fry talking about 9.72 million shares priced at 18 bucks a pop. This isn't just any run-of-the-mill company; they claim to have the first peptide-containing formulation for early...

Continue Reading
CSTS Backs Hong Kong's Nobel Sustainability Trust Put

Updated Category News Views 150

A New Chapter for CSTS and Sustainability Leadership Who would've thunk it? CSTS Enterprises, primarily known for its integrated media and sports ventures, is stepping into the sustainability arena as the Official Hospitality Partner for the Nobel Sustainability Trust Hong Kong Summit 2026. They're not just dipping a toe—they're diving headfirst into the pool, bringing...

Continue Reading
Why Surge Protection Is Now a Vital Home Upgrade

Updated Category News Views 83

Understanding the Hidden Risks of Power Surges You ever had a computer or TV go kaput out of the blue? Chances are, power surges are the stealthy culprit. Zachary Bobersky, an expert electrician from Ungerman Electric, dishes out the hard truths about how these electrical hiccups, often triggered by everyday use—like your refrigerator or AC flicking on—can quietly...

Continue Reading
CVRx Faces Legal Storm: Investors Grapple with Fallout

Updated Category News Views 124

CVRx in the Crosshairs: Legal and Operational Woes There's a storm brewing over at CVRx, Inc. (NASDAQ: CVRX), and it's pulling investors down a hell of a financial rabbit hole. You might think you're in the clear with a company like CVRx that boasts approved devices, but think again. Recent revelations have shown that even those with FDA stamps aren't immune to the...

Continue Reading
DraftKings Shares Tumble, Investors Grapple with Losses

Updated Category News Views 60

DraftKings' Bold Moves Hit Investor Pockets Hard It ain't every day you see a company gamble nearly $700 million and come out with egg on its face. Yet, that's what DraftKings (NASDAQ: DKNG) seems to have done, and now it's shareholders who might be left holding the bag. On November 6, 2026, when DraftKings admitted it was doubling down on its Predictions business...

Continue Reading
Fly-E Faces Revenue Drop Amid Retail Restructuring

Updated Category News Views 131

Downturn Despite Strategic Restructuring Today, we're diving into Fly-E Group, Inc. (NASDAQ:FLYE) and the latest shakeup in their financials—spoiler alert, it's riding a downward slope. Quarter two of fiscal 2027 didn't exactly shine a light on profitability. Net revenues slid, dropping to $2.6 million this quarter, down from $3.9 million the previous year. Tack that up...

Continue Reading
Revolutionary Sports Ball Backpack: A Game Changer?

Updated Category News Views 37

Backpacks Reinvented by a Clever Mom Ever been caught in the whirlwind of juggling kids, sports gear, and school supplies? Well, one stay-at-home mom from Poway, California found herself in just such a predicament. She turned this everyday chaos into a creative solution by designing a unique Sports Ball Backpack. The idea came to her while managing a toddler, a newborn,...

Continue Reading
Mitsubishi CEO Chikumoto Wins 2026 Palladium Medal

Updated Category News Views 147

Here's something to tip your hat to: Manabu Chikumoto, the head honcho of Mitsubishi Chemical Group, snagged the 2026 International Palladium Medal. You don't get this one by just sitting pretty behind a desk. The folks at the Société de Chimie Industrielle—the ones responsible for this prestigious accolade—know a thing or two about setting high bars in the chemical...

Continue Reading
Thanksgiving in Outer Banks: Unique Traditions Await

Updated Category News Views 65

Thanksgiving Plans Off the Beaten Path Thanksgiving in the Outer Banks isn't just another holiday; it's a whole different ball game. Imagine trading in the usual family couch-potato marathon for a beachside gathering, where the sand replaces the snow, and coastal seafood joins the turkey on your dinner table. If you've been teetering on the edge of making plans, this...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Female Athletes: Herbalife Supports Basketball Combine

Updated Category News Views 324

Herbalife Partners for Women’s College Basketball Stars Herbalife, a leading health and wellness brand, is stepping up to empower female athletes by becoming the Official Nutrition and Hydration Partner for the Lilly 2025 Women's College All-Star Combine. This significant event aims to showcase talented basketball players, allowing them to connect with scouts and...

Continue Reading
FPI Earnings Preview: Traders Eye EPS and Guidance Impact

Updated Category News Views 167

Farmland Partners (NYSE:FPI) is prepped to drop its quarterly earnings on February 18, 2026, and you better believe traders are already sweating over it. Analysts are throwing out estimates pegging the earnings per share (EPS) at $0.19—now, that's not exactly a home run but it's enough to keep eyes glued to the screens as we await the news. The buzz in the air is thick;...

Continue Reading
Celebrate Mom with a Prize from Molly Maid This Mother's Day

Updated Category News Views 138

Celebrate Mother's Day with Molly Maid’s Special Giveaway Mother's Day is a wonderful occasion to honor and pamper the incredible mothers in our lives. This year, Molly Maid® is offering a unique opportunity to celebrate these remarkable women with their annual "Mother's Day Clean Home Giveaway." This giveaway presents a chance for five fortunate winners to each...

Continue Reading
Cure Alzheimer's Fund Welcomes New Research Management Leader

Updated Category News Views 190

Cure Alzheimer's Fund Welcomes New Research Management Leader Cure Alzheimer's Fund is thrilled to announce the appointment of Natasha Hussain, Ph.D., as the new Executive Vice President for Research Management. In her new role, Dr. Hussain is poised to manage and enhance the research opportunities and funding initiatives within the organization. Bringing Expertise to...

Continue Reading
Understanding Disclosure Requirements for Life Science REIT

Updated Category News Views 142

Overview of Disclosure Requirements Understanding the importance of disclosure in the financial world is pivotal for investors. When companies like Life Science REIT Plc are involved, transparency in trading and ownership stakes is crucial. Efforts to remain compliant under various regulations can help build trust among stakeholders and investors alike. Key Entities and...

Continue Reading